BIOVECTRA
11 Aviation Avenue, Charlottetown, PE C1E 0A1
Canada
T: (866) 883-2872
E: solutions@biovectra.com
W: https://www.biovectra.com/
LinkedIn: https://www.linkedin.com/company/biovectra-inc-

 

BIOVECTRA
We care about making better therapeutics.

BIOVECTRA, now part of Agilent Technologies, is a global biotech and pharmaceutical CDMO that specializes in clinical-to-commercial scale production capabilities for biologics, small molecules, bioreagents, pDNA and mRNA manufacturing, and fill/finish. Flexibility, creativity, process optimization, and compliance are at the heart of our method. Our teams leverage decades of expertise and a proven track record of excellence to optimize, adapt, and perfect innovative technologies and drug substance development approaches to deliver world-class solutions for pharmaceutical manufacturing.

• 50+ years of pharmaceutical manufacturing experience
• Flexible, creative systems designed to deliver solutions quickly and efficiently
• Extensive regulatory expertise backed by long standing relationships with major regulatory bodies

Our Facilities:

• 8 cGMP facilities in Atlantic Canada​
• 270,000+ sq ft manufacturing facility​
• 118,000 L of chemical reactor space​
• 64,000 L of fermentation bioreactor capacity

Accelerate the Success of Your mRNA Therapeutics with BIOVECTRA

Looking for a reliable partner to advance your nucleic acid program?

BIOVECTRA is accepting projects at its state-of-the-art biomanufacturing center located in Prince Edward Island, Canada. The facility features 36,000 square feet of cGMP manufacturing space for mRNA, pDNA and lipid nanoparticle formulation, vaccine and therapeutic production capacity for 160 million doses per year, and fill/finish capacity for 70 million doses per year for commercial distribution.

Our experienced team excels in custom lipid manufacturing. With more than 50 years of expertise in fermentation, small molecule production, and quality management for regulatory compliance, we ensure scalability and precision at every production stage.

As a full-service CDMO, BIOVECTRA offers analytical testing, QA release, regulatory support, project management, and more.

Learn more at www.BIOVECTRA.com.